Henderik W. Frijlink

Professor and chairman

University of Groningen

Netherlands

Research Interests

Explore related searches

Professors in Netherlands

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Henderik W. Frijlink is a Professor and chairman at the University of Groningen, Netherlands. His research focuses on inhalable drug formulations, pulmonary therapies, and compounding practices in pharmacy. Recent articles include studies on dry powder products for inhalation and their applications in treating conditions such as cystic fibrosis and Parkinson's disease.

Articles (23)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Collaborators (9)

Wouter L. J. Hinrichs

University of Groningen

NETHERLANDS

View details

Marjo Campmans-Kuijpers

Assistant professor/clinical epidemiologist/research dietitan

University Medical Center Groningen

NETHERLANDS

View details

Daan J. Touw

University Medical Center Groningen

NETHERLANDS

View details

Bahez Gareb

Universitair Medisch Centrum Groningen (UMCG)

NETHERLANDS

View details

Mitchel JR Ruigrok

University of Groningen

NETHERLANDS

View details

Alessia Lasorsa

University of Groningen

NETHERLANDS

View details

Herman J. Woerdenbag

University of Groningen

NETHERLANDS

View details

Gerard Dijkstra

NETHERLANDS

View details

Christian Schöneich

University of Kansas

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Henderik W. Frijlink

Research Interests

Explore related searches

Contact this professor

About

Articles (23)

Extemporaneous Compounding, Pharmacy Preparations and Related Product Care in the Netherlands

An In Vitro–In Vivo Comparison of Two Levodopa Dry Powder Products for Inhalation: A Randomized Trial Comparing Inbrija and Levodopa Cyclops

Development of a stable inhalable dry powder formulation with osteoglycin fragment for alveolar epithelial repair

Azithromycin as host-directed therapy for pulmonary tuberculosis - a randomized pilot trial

Fibroblast-derived osteoglycin promotes epithelial cell repair

Tolerability and Pharmacokinetic Evaluation of Inhaled Dry Powder Tobramycin in Children with Cystic Fibrosis

Stabilized Extracellular Vesicle Formulations for Inhalable Dry Powder Development

What Is the Optimal Geometry of Dissolving Microneedle Arrays? A Literature Review

Combinations of arginine and pullulan reveal the selective effect of stabilization mechanisms on different lyophilized proteins

Critical review on the role of excipient properties in pharmaceutical powder-to-tablet continuous manufacturing

Inhibition of influenza virus infection in mice by pulmonary administration of a spray dried antiviral

Therapeutic effect of an inhaled levodopa dry powder formulation on off episodes in patients with Parkinson's disease

Effects of ileocolonic delivered vitamin B<sub>2</sub>, B<sub>3</sub> and C (ColoVit) or the Groningen anti-inflammatory diet on disease course and microbiome of patients with Crohn's disease (VITA-GrAID study): a protocol for a randomised and partially blinded trial.

Nebulization of PEGylated recombinant human deoxyribonuclease I using vibrating membrane nebulizers

Surface Engineering Methods for Powder Bed Printed Tablets to Optimize External Smoothness and Facilitate the Application of Different Coatings

Performance Testing of a Homemade Aerosol Generator for Pulmonary Administration of Dry Powder Formulations to Mice

Clinical Validation of a Capillary Blood Home-Based Self-Sampling Technique for Monitoring of Infliximab, Vedolizumab, and C-Reactive Protein Concentrations in Patients With Inflammatory Bowel Disease

Development of an inhalable antiviral powder formulation against respiratory syncytial virus

Capsules with Ileocolonic-Targeted Release of Vitamin B2, B3, and C (ColoVit) Intended for Optimization of Gut Health: Development and Validation of the Production Process

Designing Formulation Strategies for Enhanced Stability of Therapeutic Peptides in Aqueous Solutions: A Review

A Single Injection with Sustained-Release Microspheres and a Prime-Boost Injection of Bovine Serum Albumin Elicit the Same IgG Antibody Response in Mice

Inhalation of vaccines and antiviral drugs to fight respiratory virus infections

Are inhaled mRNA vaccines safe and effective? A review of preclinical studies

Collaborators (9)

Wouter L. J. Hinrichs

Marjo Campmans-Kuijpers

Daan J. Touw

Bahez Gareb

Mitchel JR Ruigrok

Alessia Lasorsa

Herman J. Woerdenbag

Gerard Dijkstra

Christian Schöneich

Make your next move.